Eric Jeffrey Vick, MD, PhD

Physician-Scientist in hematology and oncology interested in leukemogenesis and immunotherapy.

Bachelors of Science: University of Tennessee Knoxville Knoxville, TN, 2009 (Biochemistry, Cellular, and Molecular Biology)

Doctor of Philosophy: Middle Tennessee State University Murfreesboro, TN, 2014 (Immunology, Microbiology, and Molecular Biosciences.)

Doctor of Medicine: University of Tennessee Health Science Center Memphis, TN, 2018 (Medicine)

University of Cincinnati Cincinati, OH, 2020 (Internal Medicine)

Residency : University of Cincinnati Cincinnati, 2020 (Internal Medicine Residency)

Fellowship : University of Cincinnati Cincinnati, 2024 (Hematology/Oncology Fellowship)

American Board of Internal Medicine (Certification Date: 08-16-2021 )

American Board of Internal Medicine (Medical Oncology) (Certification Date: 10-09-2024 )

Hematology

Hematology and Oncology

N/A

Internal Medicine

Medical Oncology

Grant: #Back to Bedside Grant Agreement 07-01-2019 -06-30-2022 Accreditation Council for Graduate Medical Education Back to Bedside Initiative Role:PI 5000.00 Active Level:Non Profit

Grant: #Back to Bedside Grant Agreement 07-01-2019 -06-30-2022 Accreditation Council for Graduate Medical Education Back to Bedside Initiative Role:PI 5000.00 Active Level:Non Profit

Grant: #ASCO-2024YIA-1260731917 Investigators:Vick, Eric 07-01-2024 -06-30-2025 Asco Foundation Targeting myeloid malignancies through IRAK4 synthetic lethality dependencies Role:PI 50000.00 Hold Level:Non Profit

Grant: #Vick - ASCO Investigators:Vick, Eric 07-01-2024 -06-30-2025 Leukemia & Lymphoma Society Targeting Myeloid Malignancies through IRAK4 Synthetic Lethality Dependencies Role:PI 50000.00 Hold Level:Non Profit

Grant: #LLS CDP 5682-25 Investigators:Vick, Eric -06-30-2027 Leukemia & Lymphoma Society Targeting Myeloid Malignancies through IRAK4 Synthetic Lethality Dependencies Role:PI 0.00 Hold Level:Non Profit

Peer Reviewed Publications

Vick, Eric; Sharma, Divya; Elwing, Jean  (2021). Raynaud Phenomenon in Antisynthetase Syndrome Treated With Epoprostenol. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 27 (1) , e10-e11More Information

Vick, Eric J; Richardson, Noah; Patel, Kruti; Delgado Ramos, Glenda M; Altahan, Alaa; Alloway, Taylor; Martin, Michael G  (2018). Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma: An In Silico Approach. World journal of oncology, 9 (4) , 97-103More Information

Vick, Eric J; Clark, Christopher T; Lewis, James M  (2018). Radiation-Induced Sarcoma following Prolonged Coronary Stent Placement. Case reports in surgery, 2018, 2903801More Information

Stein, Matthew K; Crawley, Melissa; Vick, Eric; Martin, Mike G  (2018). Concomitant ATM Mutations Identified by Next Generation Sequencing in a Patient With New-Onset Acute Myeloid Leukemia Following Imatinib Treatment for Chronic Myeloid Leukemia. World journal of oncology, 9 (2) , 66-67More Information

Islam, Shariful; Vick, Eric; Huber, Bryan; Morales, Carla; Spier, Catherine; Cooke, Laurence; Weterings, Eric; Mahadevan, Daruka  (2017). Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: a novel therapeutic strategy. Oncotarget, 8 (59) , 100326-100338More Information

Vick, Eric J; Patel, Kruti; Prouet, Philippe; Martin, Mike G  (2017). Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy. Blood advances, 1 (12) , 779-791More Information

Kidane, Destaalem T; Arivett, Brock A; Crigler, Jacob; Vick, Eric J; Farone, Anthony L; Farone, Mary B  (2017). Draft Genome Sequence of Gardnerella vaginalis Strain ATCC 49145 Associated with Bacterial Vaginosis. Genome announcements, 5 (18) More Information

Park, Hyo S; Vick, Eric J; Gao, Ying; He, Chunnian; Almosnid, Nadin Marwan; Farone, Mary; Farone, Anthony L  (2016). Cis- and Trans-gnetin H from Paeonia suffruticosa suppress inhibitor kappa B kinase phosphorylation in LPS-stimulated human THP-1 cells. Journal of ethnopharmacology, 189, 202-9More Information

Vick, Eric; Mahadevan, Daruka  (2016). Programming the immune checkpoint to treat hematologic malignancies. Expert opinion on investigational drugs, 25 (7) , 755-70More Information

Gao, Ying; Huang, Renbin; Gong, Yixuan; Park, Hyo Sim; Wen, Qingwei; Almosnid, Nadin Marwan; Chippada-Venkata, Uma D; Hosain, Najlaa Abdulrhman; Vick, Eric; Farone, Anthony; Altman, Elliot  (2015). The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells. Oncotarget, 6 (27) , 24304-19More Information

Vick, Eric J; Park, Hyo S; Huff, Krista A; Brooks, Kenneth M; Farone, Anthony L; Farone, Mary B  (2014). Gardnerella vaginalis triggers NLRP3 inflammasome recruitment in THP-1 monocytes. Journal of reproductive immunology, 106, 67-75More Information

Muto, Tomoya; Walker, Callum S; Agarwal, Puneet; Vick, Eric; Sampson, Avery; Choi, Kwangmin; Niederkorn, Madeline; Ishikawa, Chiharu; Hueneman, Kathleen; Varney, Melinda; Starczynowski, Daniel T  (2023). Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation. Haematologica, 108 (10) , 2715-2729More Information

Bennett, Joshua; Ishikawa, Chiharu; Agarwal, Puneet; Yeung, Jennifer; Sampson, Avery; Uible, Emma; Vick, Eric; Bolanos, Lyndsey C; Hueneman, Kathleen; Wunderlich, Mark; Kolt, Amal; Choi, Kwangmin; Volk, Andrew; Greis, Kenneth D; Rosenbaum, Jan; Hoyt, Scott B; Thomas, Craig J; Starczynowski, Daniel T  (2023). Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML. Blood, 142 (11) , 989-1007More Information

Clancy, Kate; Hamill, Chelsea S; O'Neill, W Quinn; Vu, Brandon; Thuener, Jason; Gui, Shanying; Li, Shawn; Fowler, Nicole; Rezaee, Rod; Lavertu, Pierre; Wasman, Jay; Patel, Monaliben; Shaikh, Hira; Vick, Eric; Madabhushi, Anant; Wise-Draper, Trisha M; Burkitt, Kyunghee; Teknos, Theodoros N; Pan, Quintin  (2021). Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients. Cancers, 13 (19) More Information

Vick E.J., Hassan A, Choi K, Bennett J, Muto T, Culver-Cochran AE, Hueneman K, Bolanos LC, Wunderlich M, Zhang X, McKnight C, Ceribelli M, Holland D, Klumpp-Thomas C, Greis K, Thomas CJ, Starczynowski DT  (2025). Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in myeloid malignancies via c-Myc destabilization. Leukemia, 39 (9) , 2163-2173

Vick E.J., and Starczynowski, D.T.  (2025). IRAK signaling in cancers: mechanisms, targeting, and clinical implications. Exp Opin Inv Drugs, 2025 Oct (15) , 1-18

Vick, Eric J; Starczynowski, Daniel T  (2025). IRAK signaling in cancers: mechanisms, targeting, and clinical implications. Expert opinion on investigational drugs, 34 (10) , 775-792More Information

Vick, Eric J; Hassan, Aishlin; Choi, Kwangmin; Bennett, Joshua; Muto, Tomoya; Clough, Courtnee A; Culver-Cochran, Ashley E; Hueneman, Kathleen; Bolanos, Lyndsey C; Wunderlich, Mark; Zhang, Xiaohu; McKnight, Crystal; Ceribelli, Michele; Holland, David; Klumpp-Thomas, Carleen; Greis, Kenneth D; Thomas, Craig J; Starczynowski, Daniel T  (2025). Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization. Leukemia, 39 (9) , 2163-2173More Information

Poster Presentations

Eric Vick, Inas Abuali, Sarah Ludvigson, Andrew Kelleher, Nicholas Arias, Nathaniel Moore, Marcus Trybula, Lisa Grate, Shuchi Gulati, Trisha Wise-Draper (10-2020. ) Antibiotic Administration Prior to Immunotherapy Leads to Poor Overall Survival Across Multiple Malignancies .Society for Immunotherapy of Cancer, Online. . Professional Meeting. . Level:International

Eric Vick, Inas Abuali, Sarah Ludvigson, Andrew Kelleher, Nicholas Arias, Nathaniel Moore, Marcus Trybula, Lisa Grate, Shuchi Gulati, Trisha Wise-Draper (10-2020. ) Immune-related adverse events associated with immune checkpoint inhibitor therapy are associated with enhanced survival and disease-specific incidence .Society for Immunotherapy of Cancer, Online. .